Percutaneous endoscopic gastrojejunostomy in pediatric intestinal pseudo-obstruction.

Endoscopic gastrojejunostomy Intestinal decompression Nutritional support Severe gut dysmotility Small intestine bacterial overgrowth

Journal

Nutrition (Burbank, Los Angeles County, Calif.)
ISSN: 1873-1244
Titre abrégé: Nutrition
Pays: United States
ID NLM: 8802712

Informations de publication

Date de publication:
06 2021
Historique:
received: 03 01 2021
accepted: 23 01 2021
pubmed: 19 2 2021
medline: 24 6 2021
entrez: 18 2 2021
Statut: ppublish

Résumé

Pediatric intestinal pseudoobstruction (PIPO) is the "tip of the iceberg" of the most severe gut motility disorders. In patients with PIPO, the impairment of gastrointestinal propulsive patterns is such as to result in progressive obstructive symptoms without evidence of mechanical causes. PIPO is an important cause of intestinal failure and affects growth and pubertal development. Bowel loop and abdominal distension represent one of the main features of intestinal pseudo-obstruction syndromes, hence intestinal decompression is a mainstay in the management of PIPO. So far, pharmacologic, endoscopic, and surgical treatments failed to achieve long-term relief of bowel distension and related symptoms, including pain. Recent data, however, indicated that percutaneous endoscopic gastrojejunostomy (PEG-J) might be a minimally invasive approach for intestinal decompression, thereby improving abdominal symptoms and nutritional status in adult patients with chronic intestinal pseudo-obstruction. Based on these promising results, we treated for the first time a 12-y-old patient affected by PIPO refractory to any therapeutic options to obtain intestinal decompression by PEG-J. We showed that PEG-J yielded sustained small bowel decompression in the reported PIPO patient with considerable improvement of both abdominal symptoms and nutritional status. The positive outcome of the present case provides a basis to test the actual efficacy PEG-J versus other therapeutic approaches to intestinal decompression in patients with PIPO.

Identifiants

pubmed: 33601120
pii: S0899-9007(21)00036-8
doi: 10.1016/j.nut.2021.111174
pii:
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

111174

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Giovanni Di Nardo (G)

NESMOS Department, Pediatric Unit, Faculty of Medicine & Psychology, Sapienza - University of Rome, Sant'Andrea University Hospital, Rome, Italy. Electronic address: giovanni.dinardo@uniroma1.it.

Maria Beatrice Manca (MB)

Department of Medical-Surgical and Translational Medicine, Anesthesia and Intensive Care Unit, Sant'Andrea University Hospital, Sapienza University of Rome, Rome, Italy.

Elsa Iannicelli (E)

Department of Medical-Surgical and Translational Medicine, Radiology Unit, "Sapienza" University of Rome, Sant'Andrea Hospital, Rome, Italy.

Giancarlo D'Ambra (G)

Department of Medical-Surgical Sciences and Translational Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.

Alessandro Laviano (A)

Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.

Matteo Guarino (M)

Department of Translational Medicine, University of Ferrara, Ferrara, Italy.

Pasquale Parisi (P)

NESMOS Department, Pediatric Unit, Faculty of Medicine & Psychology, Sapienza - University of Rome, Sant'Andrea University Hospital, Rome, Italy.

Francesco Ernesto Pontieri (FE)

NESMOS Department, Neurology Unit, Faculty of Medicine & Psychology, Sapienza - University of Rome, Sant'Andrea University Hospital, Rome, Italy &Department of Clinical and Behavioral Neurology, IRCCS - Fondazione Santa Lucia, Rome, Italy.

Elisa Rosati (E)

Department of Medical-Surgical and Translational Medicine, Radiology Unit, "Sapienza" University of Rome, Sant'Andrea Hospital, Rome, Italy.

Roberto De Giorgio (R)

Department of Translational Medicine, University of Ferrara, Ferrara, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH